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Abstract 
This paper explores the cost-effectiveness of New York State-approved syringe exchange 
programs (SEPs), and provides an estimate of the annual savings in healthcare costs due to these 
programs. The research utilizes the simplified circulation model that estimated cost savings in 
Laufer’s (2001) study, however with the most recent data. The cost-effectiveness analysis used 
data provided by seventeen SEPs, as well as published data for the most recent 12-month period 
available, and treatment costs from the literature. An estimated 1,608 human immunodeficiency 
virus (HIV) cases are averted annually in the injection drug user (IDU) population, which 
translates to about $51,754,152 in treatment cost savings each year due to syringe exchange 
programs in New York. This research further demonstrates the cost-effectiveness of syringe 
exchange as prevention strategy. 
Keywords: Injection drug user, syringe exchange, HIV cost-effectiveness 
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Reducing Healthcare Costs in New York with Syringe  
Exchange Program Implementation 
Many studies have been conducted that demonstrate the effectiveness of syringe 
exchange programs in reducing HIV transmission, yet they are still controversial despite their 
success. SEPs provide clean syringes and collect used syringes from IDUs in an effort to reduce 
the spread of blood borne pathogens, such as HIV, hepatitis B virus, and hepatitis C virus. 
Injection drug users typically do not use sterile syringes, and through blood to blood contact, 
many blood pathogens are spread through them. The effects of SEPs are indeed a decrease in the 
spread of viruses, and even drug use. An additional effect is a decrease in healthcare costs due to 
SEP cost-effectiveness. For example, a clean syringe costs less than 50 cents, but the average 
lifetime cost of treating an HIV-positive person is around $425,000, and up to $300,000 for 
hepatitis C treatment (Frost, 2015). SEPs are primarily focused in prevention instead of 
treatment, an approach that should be prioritized, implemented, and funded more thoroughly. 
Further syringe exchange program implementation could greatly reduce the cost of healthcare in 
New York. By reviewing the published data and the reported data of each of the New York 
State-approved SEPs, the cost savings can be calculated. 
A History of Syringe Exchange 
The history of SEPs is a short one. Injection drug users can spread blood pathogens 
through the blood to blood contact which is involved in using un-sterile syringes. This fact was 
largely ignored up until the 1980s, when the AIDS epidemic was getting out of control. The 
Centers for Disease Control and Prevention (CDC) learned that the virus was spread through 
blood or sexual contact, and the realization dawned that they could potentially decrease the 
number of people infected by providing IDUs with clean syringes.  
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Affected Population: Injection Drug Users 
It took a long while for the creation of a public health program idea such as SEPs, largely 
due to the fact that the population negatively affected is made up of drug users. In fact, many of 
the objections to SEPs seem to be grounded less in the effectiveness of the programs, and more 
in the stigmatizing of drug users and disapproval of drug use (Brownstein, 2014). Injection drug 
users are often treated as outcasts or untouchables by social service agencies, which is why the 
idea to offer them clean syringes to save their lives was such a large shift. This population is 
engaging in criminal acts, which reduces the opportunity for healthcare providers to offer 
counseling and rehabilitation services (Syringe Exchange Program, 2015). Syringe exchange 
programs are often the only resource in the community which is capable of engaging injection 
drug users in mental health or harm reduction psychotherapy services (Anderson, 2013). These 
programs act as a gateway for IDUs to receive help. The IDU population is large; in 2011, the 
number of heroin users in the U.S. was 620,000, and increasing (Delivering Harm Reduction 
Services Including Syringe Exchange, 2013). 
Syringe Exchange Opposition 
Critics of syringe exchange programs (SEPs) maintain the position that the programs 
encourage drug use, even though numerous studies have found that they actually reduce drug 
use. Individuals who support SEPs use the following scenario to argue against this statement: 
Your county begins providing sterile syringes to injection drug users. Would this tempt 
you to begin using heroin? No, this would not (Ingraham, 2015). 
Another possible opposition argument is the possible negative outcome of an increase in the 
number of improperly discarded used syringes. A study conducted in 2012 which compared 
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Miami and San Francisco answered to this argument. It was found that there were eight times 
more discarded used syringes on the streets of Miami, even though Miami had no SEP at the 
time and half as many injection drug users as San Francisco, a city which had many SEPs 
(Tookes, Kral, Wenger, Cardenas, Martinez, Sherman & Metsch, 2012). 
Not all the arguments opposing SEPs should be dismissed. Another opposition argument 
is the possibility that the government issuance of injection equipment will send a message 
weakening efforts to combat illegal drug use, and will promote more drug use. A similar 
argument is the possible negative outcome that SEPs will lower the perception of risk of 
injection drug use, and encourage more users to inject drugs and to move to other forms of illegal 
drug use. Additionally, the negative outcome of increased arrests, as well as problems with the 
law exist (Normand, Moses & Vlahov, 1995). Many studies have shown that syringe exchange 
does not increase drug use or crime. These studies justify their findings by comparing the 
similarities between syringe exchange and providing access to condoms. In the example of 
condom access, individuals will not be having more sex. They will have the same amount of sex 
that they were having, however, they are going to have sex more safely (Delivering Harm 
Reduction Services Including Syringe Exchange, 2013). In the case of injection drug users, they 
will be injecting the same amount of drugs that they were injecting before, and they will be using 
a safer method.  
HIV, Hepatitis, and Health Risks 
About 20% of Acquired Immunodeficiency Syndrome (AIDS) cases and over 55% of 
hepatitis C cases can be attributed to injection drug use, which stresses the practicality of SEPs 
as a tool in the fight against these diseases (Cost-Effectiveness of Syringe Exchange Programs, 
2016). Infected syringes result in 3,000-5,000 transmissions of HIV each year (Centers for 
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Disease Control and Prevention, 2013). As of 2013, 116,452 New Yorkers had been diagnosed 
with HIV or AIDS; this was a 1.3% increase in the rate of persons living with HIV/ AIDS from 
2012. About 20% of those infected had injection drug use history, which is 23,290 IDUs (Paone, 
O’Brien & Tuazon, 2014). 
SEPs were first expanded in New York during the AIDS epidemic in 1992, and this was 
followed by a dramatic reduction in HIV incidence among injection drug users. The HIV 
incidence in IDUs declined from 54% in 1990 to 13% in 2001, and hepatitis C prevalence 
declined from 90% to 63% (Des Jarlais, Perlis, Arasteh, Torian, Hagan, Beatrice & Friedman, 
2005). SEPs are not only successful at reducing HIV and hepatitis viral infections, but they have 
been shown to be cost-effective, yielding substantial cost savings because treatment for these 
diseases is very expensive. By 2010, HIV/AIDS had led to the death of 600,000 Americans 
(Centers for Disease Control and Prevention, 2007). The loss of human lives as well as the 
treatment is costly to society.  
Injection drug users who use un-sterile syringes are at risk for other ailments as well, 
ranging from collapsed veins, reduced circulation, blood clots, embolisms, infections, as well as 
causing scarring and permanent damage to tissues. If the IDU decides to attempt sharpening the 
syringe, the risk of shaved off shards of metal getting inside the syringe and in turn entering the 
body is high (L, 2014). Figure 1.0 in Appendix A shows a magnified view of a syringe before 
use, after one use, and after six uses. The syringe becomes visibly damaged, and will in turn 
damage the body tissue of the IDU. These are all health risks that could cause chronic disease 
and increase health costs. Another significant risk for IDUs is overdose. In 2014 alone there were 
10,574 overdose deaths related to heroin (Castillo, 2016). Again, this loss of life is costly to 
society. 
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Politics of Syringe Exchange Over Time 
 The federal government has refused to fund SEPs since 1988. Funding continued to be 
withheld even though it was proven that SEPs have considerable benefits. While much research 
demonstrates that SEPs are essential, stigma is attached to the practice by those fearing 
promotion of risky behavior. This has made it difficult to implement programs in many places. 
Estimates of coverage in major metropolitan statistical areas ranged from .03% to as high as 
22%, with a mean of 3.2% in 1996 (The U.S. Conference of Mayors, 1996). The uneven 
placement of SEPs in the U.S. involved political, socioeconomic, and organizational 
characteristics of areas, and these factors effected service needs, resources, opposition, and 
localized action (Tempalski, 2007). 
Approximately 100,000 to 200,000 IDUs live in New York City, more than any other city 
in the United States. SEPs were established in New York in 1992 to prevent HIV transmission by 
distributing sterile syringes and injection equipment. These programs worked, yet gaps in syringe 
access continued in certain communities and areas. As of 2005, 22,000 IDUs were still living 
with HIV in New York (Frieden, 2006). Several New York City studies demonstrated that IDUs 
enrolled in SEPs decreased high-risk injection behavior such as using contaminated syringes or 
sharing injection equipment by more than 50% (Des Jarlais et al., 2005). The National Institute 
of Health reported that IDUs who have access to clean syringes reduce risky behaviors by 80%. 
Furthermore, these programs provide access to care for IDUs and connect them to services; 
studies show that participants “were five times more likely to enter drug treatment than non-
participant IDUs”, and they were more likely to stay in treatment (Hagan, McGough, Thiede, 
Hopkins, Duchin & Alexander, 2000). 
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 Despite such evidence, SEPs are continually caught in political conflict. The ban that 
was created in 1988 prevented state and local jurisdictions from spending their federal health 
dollars on these programs. The ban on federal funding was temporarily lifted in 2009, but was 
then reinstated by Congress as part of the 2010 budget negotiations. Supporters of SEPs argued 
that lifting the ban would not cost any additional money; it would simply allow states to spend 
their federally allocated dollars on SEPs. The federal government provides the majority of 
funding for all HIV prevention services, yet more than 200 SEPs in the U.S. were operating on 
small budgets from local and state governments (Frost, 2015). Congress ended the ban on federal 
funding for SEPs in January of 2016. The government will not fund the syringes themselves, but 
they will fund all the additional program elements and the other services provided to participants 
(Castillo, 2016). 
Today, the American Academy of Pediatrics, American Bar Association, American 
Medical Association, American Public Health Association, International Red Cross-Red 
Crescent Society, National Academy of Sciences, U.S. Conference of Mayors, World Health 
Organization, and the World Bank all officially support SEPs (Delivering Harm Reduction 
Services Including Syringe Exchange, 2013). SEPs will likely be a vital part of the statewide 
plans announced by New York Governor Andrew Cuomo to “reduce new HIV infections 
dramatically by 2020” (Frost, 2015). 
Syringe Exchange Program Details 
Syringe exchange programs (SEPs) typically deliver syringes through storefront 
programs, peer delivery programs, and outreach programs. Peer delivery and outreach are ways 
to get sterile syringes to drug users who are not willing to go into the store to get them or who 
may not know that it exists. Outreach consists of contacting people who might benefit from harm 
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reduction services. Peer delivery workers are usually former or current IDUs who have 
connections with a large network of IDUs who are unwilling to come into the storefront to obtain 
sterile syringes (Anderson, 2013). Most SEPs offer more than clean syringes; many offer 
supplies, food and drink, preventive health and clinical services, HIV and Hepatitis C counseling 
and testing, sexually transmitted disease screening, tuberculosis screening, referrals to substance 
abuse treatment, and more. SEPs not only benefit IDUs by helping to prevent the transmission of 
blood borne diseases, they also benefit the communities in which they operate by keeping 
discarded syringes off the streets, giving homeless or unstably housed IDUs alternatives to street 
involvement, and serving as a gateway to engage IDUs in services such as mental health and 
substance use counseling, housing, and case management. Many programs have a space which 
allows homeless and unstably housed IDUs to get inside off the streets and get warm in the 
winter or cool in the summer and to have a drink or some food. Finally, it is becoming more 
common for SEPs to provide training in overdose prevention and reversal, and to provide 
overdose reversal kits containing naloxone, also known as Narcan. Naloxone is the only drug 
which can save a life by reversing an opioid overdose (Anderson, 2013).  
Syringe exchange protocols include using harm reduction techniques that accept rather 
than judge participants, confidentiality, being aware of verbal and non-verbal feedback, 
providing referrals based on the participant’s needs and choices, and assuring that services are 
accessible. Methods which evaluate these programs include analysis of program outcome 
objectives and participant surveys. Data sources used for quality improvement include quarterly 
reports, periodic surveys of participants, and epidemiological data in relation to drug treatment 
referrals, HIV, Hepatitis C and other blood borne infections (Syringe Exchange Program, 2015). 
Assessment of the success of a SEP may involve measuring the numbers of syringes exchanged, 
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the cleanliness of circulating syringes, the prevalence and incidence of HIV and other needle-
borne diseases, referrals to drug treatment programs, enrollments in treatment programs, and 
changes in the risk behaviors of syringe exchange participants (Normand et al., 1995). 
Cost Effectiveness 
 Syringe exchange programs not only save lives, but also save millions of dollars in 
chronic disease treatment costs. It is estimated that a national implementation of SEPs in the late 
1980s would have saved 20,000 lives and $1.1 billion in health care costs by the year 2000 
(Frost, 2015). A 2005 Centers for Disease Control and Prevention study found that the cost to 
prevent one HIV infection by SEPs is only $4,000–$12,000 (HIV Cost-effectiveness, 2005). An 
average city would have to spend only $131,000 a year to run one SEP (about $20 per user per 
year), a small amount in comparison to the $120,000 in public health costs for one single case of 
infection (The U.S. Conference of Mayors, 1996).  
HIV and AIDS 
A sterile syringe costs between 10 and 50 cents, while the average lifetime cost of 
treating an HIV-positive person is estimated to be around $488,000. HIV-positive injection drug 
users are reporting higher levels of unemployment and homelessness, pushing the responsibility 
of cost onto public programs such as Medicaid (Frost, 2015). An analysis by Johns Hopkins 
University researchers showed that expanding the availability of SEPs to cover just 10% of all 
injections in the United States would prevent 500 new HIV infections among IDUs per year. 
This translates into $193 million in savings from prevented treatment costs; in other words, every 
dollar spent on syringe exchange saves between $3 and $7 in HIV treatment costs (Frost, 2015). 
Figure 2.0 in Appendix A demonstrates the relationship between additional investment in SEPs 
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and savings in treatment costs. SEPs in New York City alone have prevented approximately 
45,000 HIV infections since the mid-1990s, saving about $1.7 billion in treatment costs 
(Delivering Harm Reduction Services Including Syringe Exchange, 2013).  
A study conducted by Nguyen (2014) found that with an annual $10 million investment 
in SEPs 194 HIV infections would be averted, and result in treatment cost savings of $75.8 
million. A $50 million increase in funding would avert 816 infections and save $319.1 million in 
treatment costs (Nguyen, Weir, Des Jarlais, Pinkerton & Holtgrave, 2014). Based on published 
rates of needle sharing, injection frequencies and HIV prevalence, a study by Laufer (2001) 
reported that SEPs decreased HIV incidence by an estimated 60.09% during the study period, 
resulting in about 87 HIV infections averted. The median cost of each HIV infection averted was 
$41,011, and when the cost of HIV infections to society is included, the 87 averted HIV 
infections would translate into cost savings of nearly $17 million (Laufer, 2001). The data from 
New York State collected in this study shows that each infection prevented by a SEP saved over 
$20,000 in healthcare costs (Laufer, 2001). 
Hepatitis 
Hepatitis causes cirrhosis of the liver, which results in about 1,000 liver transplants each 
year, costing $500,000 for each procedure. Currently in the U.S. we are spending about $20 
million a year on SEPs. Given that the medical cost of a single infection is a half million dollars, 
we are saving money if we prevent more than 40 new infections a year (Delivering Harm 
Reduction Services Including Syringe Exchange, 2013). In 2014, the cost to provide hepatitis C 
treatment was anywhere between $84,000 and $300,000. The cost of preventing a drug-related 
infection is 150 times more cost efficient than the cost efficiency of transfusion-related infection 
(Ruiz, Gable, Kaplan, Stoto, Fineberg & Trussell, 2002). 
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Methodology 
The effects of syringe exchange programs are decreases in the spread of viruses, drug 
use, and healthcare costs. The AIDS Institute of the New York State Department of Health 
estimates that the twenty-four state-approved syringe exchange programs may be responsible for 
a 50% to 75% decline in rates of new HIV infection (New York State Department of Health, 
2014). The cost of a clean syringe is barely one dollar, and it only takes a few thousand dollars in 
SEP services to prevent a case of HIV. However, it can cost hundreds of thousands of dollars to 
treat someone with HIV. If the facts point significantly to the fact that SEPs dramatically reduce 
healthcare costs, which is a growing problem in our country, they may be more widely 
implemented.  
The annual cost savings of New York has been determined by multiplying the number of 
HIV cases averted annually by SEPs by the average annual cost of treating an HIV infection. 
Existing data was collected and analyzed to use as secondary sources. Additionally, data from 
syringe exchange programs in New York were utilized as primary sources. Data was collected 
from the programs through their websites, email, and annual reports, and include the number of 
syringes distributed annually, the number of estimated cases prevented in one year, and the 
program’s number of participants.  
Each of the 24 syringe exchange programs in New York were asked to provide 
information from the most recent 12-month period. They were asked to provide the number of 
syringes distributed annually, and the number of annual participants. 17 of the 24 programs in 
operation participated in the study. The number of HIV infections averted annually was 
estimated using a simplified circulation model. This model uses the equation E / (E + S) to 
estimate the decrease in HIV incidence through SEP participation, where E is the number of 
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syringes exchanged per client year, and S is the number of shared injections per IDU per year 
(Laufer, 2001). This decrease in HIV incidence is then applied to N, the projected number of 
SEP participants who would contract HIV in the absence of the SEP (Laufer, 2001). Multiplying 
these can be used to estimate the number of HIV infections averted annually, a number necessary 
to determine cost savings. 
Results 
 The number of HIV infections averted was estimated using the simplified circulation 
model. Calculations were based on averaged data collected from each of the participating syringe 
exchange programs in New York. The results of these calculations resulted in an estimated 1,608 
HIV infections averted each year due to SEP participation. Estimated HIV infections averted 
were rounded to the nearest whole number. 
 The parameters of the simplified circulation model can be viewed in Table B2 in the 
Appendix. The syringe exchange rate (E) was obtained by dividing the reported number of 
annually distributed syringes (b) by the estimated client-years of participation. Client-years of 
participation was determined by multiplying the reported number of annual participants (c) by 
0.483, the SEP participant attendance rate (a) (Paone, Des Jarlais, Caloir, Freidmann & Ness, 
1994). Therefore, E = 326,757 / (2,310 * .483), or E = 292.864. The number of shared injections 
per year (S) was obtained by multiplying the IDUs’ injection frequency (d) of 780 injections per 
year (Des Jarlais, Marmor, Paone, Titus, Shi, Perlis & Friedman, 1996) by the needle sharing 
rate (f) of 24.6% (Jenness, Hagan, Liu, Wendel & Murrill, 2011). Therefore, S = 780 * .246, or S 
= 191.88. The equation E / (E + S) was then used to estimate the decrease in HIV incidence 
through SEP participation (292.864 / 292.864 + 191.88). The estimated decrease in HIV 
incidence was calculated to be 60.4%. This is a slight increase from the estimated 60.09% 
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decrease in HIV incidence found in Laufer’s (2001) study. The number of SEP participants who 
would contract HIV in the absence of SEPs (N) is calculated by multiplying the reported number 
of HIV-negative participants (g) by the estimated HIV incidence among non-SEP users (i) of 
0.0526 (Des Jarlais et al., 1996). Therefore, N = 2,102 * .0526, or N = 110.5652. Applying the 
decrease in HIV incidence of 60.4% to the estimated 110.5652 SEP participants who would 
contract HIV in the absence of the SEP results in about 67 HIV infections averted. If each SEP 
averts 67 HIV infections on average each year, then the total number of HIV infections averted 
annually by New York State-approved SEPs is about 1,608. 
Conclusions 
 Using the simplified circulation model, an estimated 1,608 HIV cases are averted each 
year by the 24 syringe exchange programs in New York. According to the New York State 
Department of Health (2014), each HIV infection costs New York State $37,969 each year in 
healthcare costs (New York State Department of Health, 2014). If each of the 1,608 HIV 
infections averted saves $37,969, the total savings each year is about $61,054,152. In fiscal year 
2013/2014, total funding for New York State SEPs totaled $9.3 million (New York State 
Department of Health, 2014). If the annual cost to run the SEPs is subtracted from the estimated 
total annual savings, New York State is left with $51,754,152 in healthcare cost savings each 
year. These calculations further demonstrate the cost-effectiveness of syringe exchange as 
prevention strategy. Prevention should be the primary focus for aiding the IDU population, and 
as an added benefit treatment costs can be avoided entirely in some cases. SEPs should no longer 
be viewed as controversial, and the government should encourage the implementation of more 
state-approved programs. With more comprehensive and up-to-date evaluation of SEPs to 
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provide evidence of the full range of benefits of these programs as a prevention strategy, these 
programs will gain wider acceptance and more funding. 
It should be noted that the results estimate the number of primary HIV infections averted. 
No attempt was made to estimate the number of secondary infections resulting from already 
infected participants. Additionally, no attempt was made to calculate the cost savings from 
hepatitis infections averted, or any other infection resulting from injection drug use. It should 
also be noted that the results used were based on reported data that was averaged together. This 
data does not reflect the size differences between syringe exchange programs throughout New 
York. Several programs are very large, and almost certainly avert more than 67 HIV infections 
each year. Future studies are needed to calculate the total cost savings when secondary 
infections, as well other infections, are considered. Additionally, future studies should be 
conducted which gather data from all of the New York State-approved SEPs, so that HIV 
infections averted may be calculated for each program and SEP size may be considered.  
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Appendix A 
 
 
Figure 1.0: Syringe Use (Vieira, 2014) 
 
 
Figure 2.0: Relationship Between Investment in SEPs and Savings in Treatment Costs 
(Nguyen, Weir, Pinkerton, Des Jarlais & Holtgrave, 2012) 
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Figure 3.0: New York State-Approved Syringe Exchange Program Locations (Zagari, 2017) 
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Appendix B 
 
Table B1: Averaged SEP Data Reported 
Syringe 
Exchange 
Program 
Locations 
Average 
Annual 
Client # 
(c) 
Average 
Annual 
Syringes 
Distributed # 
(b) 
Sources 
ACR Health 
Syracuse 
Utica 
2,083  
Access Care and 
Resources Health, 
2017 
After Hours 
Project 
Brooklyn 4,497  
New York State 
Department of 
Health, 2014 
AIDS Center of 
Queens County 
Woodside 
Far Rockaway 
Jamaica 
Long Island City 
2,823  
New York State 
Department of 
Health, 2014 
Alliance for 
Positive Health 
Plattsburgh 
Ticonderoga 
275 456,108 Gibbons, 2017 
BOOM!Health Bronx 8,285 256,288 
New York State 
Department of 
Health, 2014 
BOOM!Health, 
2014 
Catholic Charities 
AIDS Services 
Albany 
Schenectady 
Troy 
707  
New York State 
Department of 
Health, 2014 
Community 
Action for Social 
Justice 
Long Island    
Community 
Health Action of 
Staten Island 
Staten Island 1,182  
New York State 
Department of 
Health, 2014 
Evergreen Health 
Services 
West Buffalo 
Jamestown 
   
Family Services 
Network of NY 
Brooklyn    
Harlem United 
Community AIDS 
Center 
Bronx  200,000 
Harlem United, 
2014 
Housing Works Manhattan 822 85,525 
Housing Works, 
2015 
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Hudson Valley 
Community 
Services Inc. 
Newburgh 
Poughkeepsie 
461 126,200 Dewey, 2017 
Long Island 
Minority AIDS 
Coalition 
Hempstead 675  
New York State 
Department of 
Health, 2014 
Lower East Side 
Harm Reduction 
Center 
Manhattan    
NY Harm 
Reduction 
Educators 
Bronx 3,257 776,944 
Syringe 
Exchange, 2015 
Positive Health 
Project 
Manhattan    
Safe Horizon NYC 1,339  
New York State 
Department of 
Health, 2014 
Southern Tier 
AIDS Program 
Ithaca 
Johnson City 
600 541,116 O’Connor, 2015 
St. Ann’s Corner 
of Harm 
Reduction 
Bronx 8,600  
St. Ann’s Corner 
of Harm 
Reduction, 2016 
Trillium Health Rochester 762  
Trillium Health & 
Pleasant Street 
Apothecary, 2014 
Urban League of 
Westchester 
Mount Vernon    
VOCAL-NY Brooklyn 375  
New York State 
Department of 
Health, 2014 
Washington 
Heights Corner 
Project 
Washington 
Heights 
2,525 171,878 
Washington 
Heights Corner 
Project, 2016 
Averages  2,310 326,757  
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Table B2: Simplified Circulation Model Parameters 
 
Variable Value Source 
E (number of syringes 
exchanged annually) 
E = b / (c * a) Laufer, 2001 
a (client attendance 
rate) 
.483 Laufer, 2001 
Paone et al., 1994 
b (syringes distributed 
annually) 
326,757 SEP data 
c (number of clients 
annually) 
2,310 SEP data 
S (number of shared 
injections per IDU 
annually) 
S = d * f 
S = 191.88 
Laufer, 2001 
d (IDU injection 
frequency) 
780 injections per 
year 
Des Jarlais et al., 1996 
f (rate of injection 
sharing among IDUs) 
.246 Jenness et al., 2011 
g (number of HIV-
negative clients) 
g = c * h 
2,102 
SEP data 
h (percent of IDUs 
who are HIV-positive) 
.09 Centers for Disease 
Control and 
Prevention, 2012 
i (HIV incidence 
among non-SEP 
users) 
.0526 Des Jarlais et al., 1996 
N (Estimated number 
of IDUs who would 
contract HIV) 
N = g * i Laufer, 2001 
 
*E / E + S is the estimated decrease in HIV incidence 
*N is the estimated number of IDU’s who would contract HIV  
*(E / E + S) * N is the estimated annual number of HIV cases averted by SEPs 
 
